66YearOld Mexican Restaurant Chain Closes 38 Locations Amid Industry Challenges Westlake Corporation WLK Q1 2026 Earnings Miss EPS 077 vs 021 Expected Northern NOG Crushes Q1 2026 Estimates EPS 074 Tops Views Canvas Hack Instructure Pays Criminals to Delete Stolen Student Data A Costly Cybersecurity Crisis Snowflake Shares Surge Over 35 After Earnings Beat and 6 Billion AWS Commitment SK Hynix Achieves 1 Trillion Market Cap Amid AIDriven Surge Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles Targets Higher Income per Employee Goldman Sachs Reportedly Selected as Lead Underwriter for SpaceX IPO Signaling Landmark Deal Chinese EVs Depreciate Faster Than Rivals in German Market Report Says Mercury Valuation Surges 49 to 52 Billion in New Funding Round FMNB Q1 2026 Earnings Strong EPS Surprise of 212 Drives Investor Attention Despite Stock Dip ESI Q1 2026 Earnings EPS Beats Estimates Shares Gain Centessa Pharmaceuticals CNTA Q1 2026 Earnings EPS Miss Amid PreRevenue Phase Stock Slips Slightly COCH Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress Though Revenue Absence Raises Questions MMI Q1 2026 Earnings Narrow EPS Miss Amid Quiet Revenue Reporting Shares Edge Higher Vista Gold Corp Q1 2026 Earnings PreRevenue Stage Maintains Focus on Paredones Amarillos State Street STT Edges Lower Stays Within Range Near Key Support Invesco Municipal Trust VKQ Edges Higher Amid Cautious Trading Beneficient Warrants BENFW Remain Flat at 001 as Trading Stalls VolitionRX VNRX Surges 159 as Shares Test Key Resistance at 329 Vantage Corp VNTG Surges 7 as Momentum Builds Toward Key Resistance BNC Q3 2023 Earnings Net Loss Per Share of 010 as Company Streamlines Operations TPR Q1 2026 Earnings EPS Exceeds Estimates by 26 Damora Therapeutics Q1 2026 Earnings WiderThanExpected Loss Despite Stock Gain SAH Q1 2026 Earnings Strong EPS Beat Drives 62 Stock Surge BlackRock BLK Q1 2026 Earnings EPS Surges Past Estimates Stock Gains on Strong Core Business Dow Edges Higher as Consumer Strength Offsets Tech and Energy Weakness Beam Therapeutics BEAM Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Inhibikase Therapeutics IKT Holds Near Support Amid Narrow Trading Range